Fujimoto et al. examined in vitro whether BC cells have the potential to activate macrophages for CCL2 production by using human MDA-MB-231 cells and mouse thioglycolate (TG)-induced peritoneal macrophages. The gene discussed is CCL2; the disease is breast cancer.